i-Stitch for Bilateral Sacrospinous Ligament Fixation (SSLF) (i-StitchSSLF)

The purpose of the clinical investigation is to generate clinical data to substantiate the safety and performance of the i-Stitch device for bilateral sacrospinous ligament fixation (SSLF) in pelvic organ prolapse (POP) repair.

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Detailed Description

The i-Stitch instrument is a reusable instrument for attaching sutures to tissue with or without surgical mesh implants in urogynaecology. It is used together with the i-Stitch loading units. The use of i-Stitch for the fixation of surgical urogynaecological mesh implants (e.g. BSC Mesh, InGYNious) has already been proven in several studies.

The aim of the present retrospective study is to generate clinical data to show the safety and performance of the i-Stitch instrument in bilateral sacrospinous ligament fixation (SSLF) without the use of a surgical mesh.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bavaria
      • Munich, Bavaria, Germany, 80331
        • Isar Kliniken GmbH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with symptomatic pelvic organ prolapse indicated for a surgical intervention.

Description

Inclusion Criteria:

  • Surgery for POP
  • SSLF with usage of i-Stitch device (& i-Stitch Loading Units)
  • Concomitant procedures are allowed
  • Women minimum 18 years old
  • Written informed consent for surgery

Exclusion Criteria:

  • infection (active or latent)
  • allergies to the materials used
  • benign or malignant changes
  • anticoagulation disorders
  • autoimmune connective tissue disorders
  • any uterus pathologies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective outcome
Time Frame: 12 months
German Pelvic Floor Questionnaire ("Deutscher Beckenboden-Fragebogen")
12 months
Subjective outcome
Time Frame: 3 months
German Pelvic Floor Questionnaire ("Deutscher Beckenboden-Fragebogen")
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life (ICIQ-UI SF)
Time Frame: 12 months
urinary incontinence and its impact on quality of life using the short form of the International Consultation on Incontinence Questionnaire
12 months
Postoperative complications
Time Frame: 12 months
Complications in women undergoing bilateral SSLF using the i-Stitch
12 months
Anatomical outcome (POP-Q)
Time Frame: 12 months
Objective anatomical failure/recurrent prolapse in any anatomical compartment
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ursula Peschers, Prof. Dr., ISAR Klinikum Munich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2025

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

October 31, 2026

Study Registration Dates

First Submitted

January 28, 2025

First Submitted That Met QC Criteria

January 28, 2025

First Posted (Actual)

February 3, 2025

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 18, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe